Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AVGR
CUSIPN/A
Phone650-241-7900
Debt
Debt-to-Equity RatioN/A
Current Ratio1.75
Quick Ratio1.42
Price-To-Earnings
Trailing P/E Ratio-0.02
Forward P/E Ratio-0.25
P/E GrowthN/A
Sales & Book Value
Annual Sales$9.93 million
Price / Sales0.90
Cash FlowN/A
Price / CashN/A
Book Value($42.82) per share
Price / Book-0.04
Profitability
EPS (Most Recent Fiscal Year)($70.07)
Net Income$-48,730,000.00
Net Margins-529.24%
Return on EquityN/A
Return on Assets-187.84%
Miscellaneous
Employees65
Outstanding Shares5,560,000
Avinger (NASDAQ:AVGR) Frequently Asked Questions
What is Avinger's stock symbol?
Avinger trades on the NASDAQ under the ticker symbol "AVGR."
When did Avinger's stock split? How did Avinger's stock split work?
Shares of Avinger reverse split before market open on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.
How were Avinger's earnings last quarter?
Avinger Inc (NASDAQ:AVGR) posted its quarterly earnings data on Monday, May, 14th. The medical device company reported ($5.37) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.84) by $4.53. The medical device company earned $1.81 million during the quarter. View Avinger's Earnings History.
Are investors shorting Avinger?
Avinger saw a increase in short interest in the month of May. As of May 31st, there was short interest totalling 1,412,553 shares, an increase of 119.3% from the May 15th total of 644,042 shares. Based on an average trading volume of 6,297,299 shares, the short-interest ratio is presently 0.2 days. Currently, 25.5% of the shares of the stock are short sold. View Avinger's Current Options Chain.
Who are some of Avinger's key competitors?
Some companies that are related to Avinger include Lianluo Smart (LLIT), Valeritas (VLRX), Pro-Dex (PDEX), AIT Therapeutics (AITB), DarioHealth (DRIO), Interpace Diagnostics Group (IDXG), Biostage (BSTG), PAVmed (PAVM), STRATA Skin Sciences (SSKN), Cytori Therapeutics (CYTX), Alliqua Biomedical (ALQA), United American Healthcare (UAHC), Neurometrix (NURO), Regenicin (RGIN) and Viatar CTC Solutions (VRTT).
Who are Avinger's key executives?
Avinger's management team includes the folowing people:
- Dr. John Bush Simpson, Founder (Age 74)
- Mr. Jeffrey M. Soinski, Pres, CEO & Director (Age 56)
- Mr. Matthew B. Ferguson, Chief Bus. Officer & CFO (Age 50)
- Mr. Keith Schaefer, Chief Operating Officer
- Mr. Himanshu N. Patel, Chief Technology Officer (Age 58)
When did Avinger IPO?
(AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.
Has Avinger been receiving favorable news coverage?
Media coverage about AVGR stock has trended somewhat positive on Saturday, according to Accern. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Avinger earned a news sentiment score of 0.11 on Accern's scale. They also assigned news coverage about the medical device company an impact score of 46.66 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.
How do I buy shares of Avinger?
Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Avinger's stock price today?
One share of AVGR stock can currently be purchased for approximately $1.60.
How big of a company is Avinger?
Avinger has a market capitalization of $8.90 million and generates $9.93 million in revenue each year. The medical device company earns $-48,730,000.00 in net income (profit) each year or ($70.07) on an earnings per share basis. Avinger employs 65 workers across the globe.
How can I contact Avinger?
Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected]
MarketBeat Community Rating for Avinger (AVGR)
MarketBeat's community ratings are surveys of what our community members think about Avinger and other stocks. Vote "Outperform" if you believe AVGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVGR will underperform the S&P 500 over the long term. You may vote once every thirty days.
